First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial
Moritz Fürstenau,Matthias Ritgen,Sandra Robrecht,Julia Von Tresckow,Can Zhang,Anke Schilhabel,Michael Gregor,Patrick Thornton,Philipp Bernhard Staber,Tamar Tadmor,Vesa Lindström,Gunnar Juliusson,Ann Janssens,Mark-David Levin,Caspar Da Cunha-Bang,Christof Schneider,Neta Goldschmidt,Elisabeth Vandenberghe,Davide Rossi, Rudolf A. Benz Blood（2023）
AI 理解论文
溯源树
样例
